EHP Funds’s Cardio Diagnostics CDIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CDIO
ASM
EHP Funds's CDIO Position: Q4 2022 in Review
EHP Funds sold out of Cardio Diagnostics (CDIO) in Q4 2022, closing a stake of 3,657 shares — an estimated $1.1M sold.
EHP Funds first reported a position in CDIO in Q1 2022 and held it in 3 quarters. The position peaked at $1.1M in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q4 2022.
- EHP Funds reported no remaining Cardio Diagnostics position as of Q4 2022 after selling out during the quarter.
- EHP Funds sold 3,657 Cardio Diagnostics shares in Q4 2022, an estimated $1.1M.
- EHP Funds first reported a position in Cardio Diagnostics in Q1 2022 and held it in 3 quarters.
- EHP Funds's Cardio Diagnostics position peaked at $1.1M in Q3 2022.
- 11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2022.
Based on EHP Funds's 13F filing for Q4 2022, filed 14 Feb 2023.